Home
Brands & Services
Early Access Programs
CRO services
Data collection
Independant committees
Market Access & HEOR
Medicine acceptability
Quality assurance
Safety reporting
Statistics & Medical writing
About us
Meet our team
History & values
Compliance
Resources
ClinSearch News
cd cs Testimonials
Publications
Careers
Privacy Policy
Legal Notice
Cookies Policy
Contact

Connect with us


Publications

Check out the most recent and influential scientific publications
involving members of the ClinSearch team.

How can multidimensional assessments be standardized? Focus on medicine acceptability, from neonates to centenarians.

Elsevier
2022 Jan

Vallet T, et al.

Exploring acceptability drivers of oral antibiotics in children: findings from an international observational study

Pharmaceutics
2021 Oct

Vallet T, et al.

Adherence and acceptability of an oral antibiotic used for the prevention of pediatric urinary tract infection in Japan

Pharmaceutics
2021 Mar

Vallet T, et al.

Acceptability of a sublingual drug formulation for respiratory tract infections in children aged 3 to 5 years

Pharmaceutics
2021 Feb

Emeryk A., et al.

Acceptability of generic versus innovator oral medicines: not only a matter of taste

Drug Discovery Today
2021 Feb

Tuleu C., et al.

Acceptability in the Older Population: The Importance of an Appropriate Tablet Size

Pharmaceutics
2020 Jun

Vallet T, et al.

Medicines Acceptability in Hospitalized Children: An Ongoing Need for Age-Appropriate Formulations

Pharmaceutics
2020 Jun

Vallet T, et al.

Product Watch Report: artificial intelligence-based software as a medical device

European Commission
2020 Jul

Digital Sustainability Forum: Common Health Data Resource for Smart Health

LIKTA, Ministry of Economics, Microsoft, Embassy of France in Latvia and the French Institute
2020 Jun

Acceptability of oral liquid pharmaceutical products in older adults: palatability and swallowability issues

BMC Geriatrics
2019 Dec

Belissa E, Vallet T et al.

Sex Differences in Medicine Acceptability: A New Factor to Be Considered in Medicine Formulation

Pharmaceutics
2019 Jul

Ruiz F, Vallet T et al.

Dosage form suitability in vulnerable populations: a focus on paracetamol acceptability from infants to centenarians

PLoS ONE
2019 Aug

Ruiz F, Vallet T et al.

Anticholinergic drug use and cognitive performances in middle age: findings from the CONSTANCES cohort

J Neurol Neurosurg Psychiatry
2018 Sep

Ziad A, et al.

A Decision Support Tool Facilitating Medicine Design for Optimal Acceptability in The Older Population.

Pharma Res
2018 May

Vallet T, et al.

Methodologies for assessing the acceptability of oral formulations among children and older adults: a systematic review.

Drug Discov Today
2018 Apr

Ruiz F, et al.

Structural basis for the role of serine-rich repeat proteins from Lactobacillus reuteri in gut microbe-host interactions.

Proc Natl Acad Sci USA
2018 Mar

Sequeira S, et al.

Design and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist.

Bioorg Med Chem
2018 Feb

Clarke E, et al.

Standardised evaluation of medicine acceptability in paediatric population: reliability of a model.

J Pharm Pharmacol.
2018 Jan

Vallet T, et al.

Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries.

J Cancer Res Clin Oncol.
2018 Apr

Augustin A, et al.

Cost-effectiveness of left ventricular assist devices for patients with end-stage heart failure: analysis of the French hospital discharge database.

ESC Heart Fail.
2018 Feb

Tadmouri A, et al.

High quality standards for a large-scale prospective population-based observational cohort: Constances.

BMC Public Health
2016 Aug

Ruiz F, et al.

Standardized method to assess medicines' acceptability: focus on paediatric population.

J Pharm Pharmacol
2017 Apr

Ruiz F, et al.

Increasing the sensitivity for stem cell monitoring in system-function based magnetic particle imaging.

Phys Med Biol.
2017 Apr

Them K, et al.

Subcutaneous immunoglobulins for the treatment of a patient with antisynthetase syndrome and secondary chronic immunodeficiency after anti-CD20 treatment: a case report.

J Med Case Rep
2017 Mar

Cherin P, et al.